$HLGN
Heliogen, Inc. Stock $hlgn

$hlgn Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000184029223000032 Filed on August 09, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$2.273M	$1.394M	$2.392M
YoY Change	-26.68%	-41.72%	183.08%
Cost Of Revenue	$1.859M	$1.522M	$2.386M
YoY Change	-45.69%	-36.21%	182.37%
Gross Profit	$414.0K	-$128.0K	$6.000K
YoY Change	-228.17%	-2233.33%
Gross Profit Margin	18.21%	-9.18%	0.25%
Selling, General & Admin	$15.00M	$17.65M	$22.59M
YoY Change	-17.91%	-21.86%	430.26%
% of Gross Profit	3622.46%		376483.33%
Research & Development	$5.162M	$4.946M	$6.147M
YoY Change	-53.78%	-19.54%	130.66%
% of Gross Profit	1246.86%		102450.0%
Depreciation & Amortization	$500.0K	$600.0K	$693.0K
YoY Change	-40.19%	-13.42%	766.25%
% of Gross Profit	120.77%		11550.0%
Operating Expenses	$20.16M	$22.60M	$28.74M
YoY Change	-31.52%	-21.36%	314.96%
Operating Profit	-$19.75M	-$22.73M	-$28.73M
YoY Change	-33.65%	-20.9%	314.87%
Interest Expense	$335.0K	$270.0K	$213.0K
YoY Change	29.34%	26.76%	-619.51%
% of Operating Profit
Other Income/Expense, Net	$767.0K	$827.0K	-$109.0K
YoY Change	-38.93%	-858.72%	-251.39%
Pretax Income	-$18.57M	-$21.68M	-$20.34M
YoY Change	-33.38%	6.58%	-63.89%
Income Tax	$1.000K	$2.000K	-$100.0K
% Of Pretax Income
Net Earnings	-$18.57M	-$21.68M	-$20.22M
YoY Change	-33.27%	7.25%	-64.11%
Net Earnings / Revenue	-816.98%	-1555.45%	-845.19%
Basic Earnings Per Share	-$3.13	-$0.11	-$0.11
Diluted Earnings Per Share	-$3.13	-$0.11	-$0.11
COMMON SHARES
Basic Shares Outstanding	205.1M shares	196.8M shares	190.2M shares
Diluted Shares Outstanding	5.936M shares	200.6M shares	190.2M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$91.62M	$107.8M	$175.9M
YoY Change	-42.55%	-38.7%	10245.47%
Cash & Equivalents	$63.40M	$43.50M	$60.73M
Short-Term Investments	$28.24M	$64.31M	$115.1M
Other Short-Term Assets	$4.410M	$4.518M	$8.179M
YoY Change	-34.92%	-44.76%	2720.34%
Inventory	$4.983M	$4.304M
Prepaid Expenses
Receivables	$5.271M	$74.00K	$500.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$106.3M	$122.4M	$189.8M
YoY Change	-38.51%	-35.48%	9437.39%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.263M	$6.426M	$6.470M
YoY Change	-37.94%	-0.68%
Goodwill	$0.00	$0.00	$984.0K
YoY Change	-100.0%	-100.0%
Intangibles			$3.555M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.764M	$5.006M	$19.72M
YoY Change	-65.5%	-74.62%	10857.78%
Total Long-Term Assets	$29.61M	$31.47M	$47.78M
YoY Change	-33.79%	-34.14%	-52.14%
TOTAL ASSETS
Total Short-Term Assets	$106.3M	$122.4M	$189.8M
Total Long-Term Assets	$29.61M	$31.47M	$47.78M
Total Assets	$135.9M	$153.9M	$237.6M
YoY Change	-37.54%	-35.21%	133.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.795M	$845.0K	$3.916M
YoY Change	-23.13%	-78.42%
Accrued Expenses	$9.440M	$9.784M	$5.794M
YoY Change	27.4%	68.86%	142.22%
Deferred Revenue	$13.17M	$12.25M	$8.500M
YoY Change	54.94%	44.08%	409.29%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$51.05M	$50.38M	$49.15M
YoY Change	4.59%	2.49%	730.3%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$26.00K
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$1.712M	$1.673M	$2.413M
YoY Change	38.85%	-30.67%	-85.1%
Total Long-Term Liabilities	$1.712M	$1.673M	$2.439M
YoY Change	36.41%	-31.41%	-84.94%
TOTAL LIABILITIES
Total Short-Term Liabilities	$51.05M	$50.38M	$49.15M
Total Long-Term Liabilities	$1.712M	$1.673M	$2.439M
Total Liabilities	$65.80M	$65.60M	$68.63M
YoY Change	-0.77%	-4.42%	265.25%
SHAREHOLDERS EQUITY
Retained Earnings	-$359.4M	-$340.8M	-$245.8M
YoY Change	31.35%	38.67%	174.41%
Common Stock	$1.000K	$20.00K	$19.00K
YoY Change	-94.74%	5.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$70.10M	$88.32M	$168.9M
YoY Change
Total Liabilities & Shareholders Equity	$135.9M	$153.9M	$237.6M
YoY Change	-37.54%	-35.21%	133.29%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$18.57M	-$21.68M	-$20.22M
YoY Change	-33.27%	7.25%	-64.11%
Depreciation, Depletion And Amortization	$500.0K	$600.0K	$693.0K
YoY Change	-40.19%	-13.42%	766.25%
Cash From Operating Activities	-$16.56M	-$14.22M	-$8.687M
YoY Change	-8.91%	63.75%	10.28%
INVESTING ACTIVITIES
Capital Expenditures	$292.0K	$327.0K	-$2.124M
YoY Change	-107.63%	-115.4%	263.08%
Acquisitions
YoY Change
Other Investing Activities	$36.73M	$17.23M	$8.206M
YoY Change	-1090.88%	109.99%	-181.04%
Cash From Investing Activities	$36.44M	$16.91M	$6.082M
YoY Change	-583.55%	177.95%	-156.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	13.00K	1.075M	678.0K
YoY Change	-90.15%	58.55%	-93.29%
NET CHANGE
Cash From Operating Activities	-16.56M	-14.22M	-8.687M
Cash From Investing Activities	36.44M	16.91M	6.082M
Cash From Financing Activities	13.00K	1.075M	678.0K
Net Change In Cash	19.89M	3.755M	-1.927M
YoY Change	-177.72%	-294.86%	-77.28%
FREE CASH FLOW
Cash From Operating Activities	-$16.56M	-$14.22M	-$8.687M
Capital Expenditures	$292.0K	$327.0K	-$2.124M
Free Cash Flow	-$16.86M	-$14.55M	-$6.563M
YoY Change	17.42%	121.73%	-10.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	40893	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	192924429	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	192924429	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	59770	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	19000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	434478000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-593000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-308580000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	125324000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	191619000	usd
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	200616841	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	200616841	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	190182474	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	190182474	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	198768335	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	198768335	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	187123737	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	187123737	shares
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-21683000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	25000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-24000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-21682000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	106028000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2816000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	168000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	927000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	168946000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	125324000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-32227000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	137000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-6490000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	168000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1162000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	88320000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	214058000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-79185000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-830000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	24506000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	915000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	168946000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-32227000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-79185000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1193000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1453000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1008000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	-6490000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	24506000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-252000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-12310000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1237000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	53000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-735000	usd
	hlg	Non Cash Lease Expense NonCashLeaseExpense	828000	usd
	hlg	Non Cash Lease Expense NonCashLeaseExpense	814000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1233000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-189000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-3331000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	1806000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1413000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1213000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3761000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2718000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	577000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2046000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	8384000	usd
	hlg	Increase Decrease In Contract Loss Provisions IncreaseDecreaseInContractLossProvisions	-934000	usd
	hlg	Increase Decrease In Contract Loss Provisions IncreaseDecreaseInContractLossProvisions	30577000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	1521000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	116000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-38357000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-31360000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	854000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3484000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	81488000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	199779000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	116500000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	40800000	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	65817000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	34158000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-96646000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	168000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1155000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	887000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1274000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1323000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-387000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2876000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-128393000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	191581000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44998000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	63188000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43498000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	60731000	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	957000	usd
CY2023Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1500000	usd
CY2022Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1500000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44998000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	63188000	usd
	hlg	Fair Value Of Warrants Issued FairValueOfWarrantsIssued	139000	usd
	hlg	Fair Value Of Warrants Issued FairValueOfWarrantsIssued	9428000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	251000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-32200000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-142000000	usd
CY2023Q2	us-gaap	Investments And Cash InvestmentsAndCash	107800000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43500000	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	64300000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and the accompanying notes. Despite our intention to establish accurate estimates and reasonable assumptions, actual results could differ materially from such estimates and assumptions.</span></div>
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1778000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3008000	usd
	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	1553000	usd
	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	2923000	usd
	us-gaap	Revenues Revenues	3331000	usd
	us-gaap	Revenues Revenues	5931000	usd
	us-gaap	Contract With Customer Receivable Credit Loss Expense Reversal ContractWithCustomerReceivableCreditLossExpenseReversal	33700000	usd
CY2022Q2	us-gaap	Contract With Customer Receivable Credit Loss Expense Reversal ContractWithCustomerReceivableCreditLossExpenseReversal	0	usd
	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	usd
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	37000000	usd
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.43
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	74000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1119000	usd
CY2022Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	7188000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	560000	usd
CY2022Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	328000	usd
CY2023Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	5820000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	9195000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	560000	usd
	hlg	Contract Assets Unbilled Receivable Additions ContractAssetsUnbilledReceivableAdditions	163000	usd
	hlg	Contract Assets Foreign Currency Translation Adjustments ContractAssetsForeignCurrencyTranslationAdjustments	10000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10348000	usd
	hlg	Contract With Customer Liability Increase For Deferred Revenue Additions ContractWithCustomerLiabilityIncreaseForDeferredRevenueAdditions	3480000	usd
	hlg	Contract With Customer Liability Revenue Recognized Excluding Opening Balance ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance	1451000	usd
	hlg	Contract With Customer Liability Recognition Of Consideration Payable Excluding Opening Balance ContractWithCustomerLiabilityRecognitionOfConsiderationPayableExcludingOpeningBalance	139000	usd
	hlg	Contract With Customer Liability Other Excluding Opening Balance ContractWithCustomerLiabilityOtherExcludingOpeningBalance	9000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	12247000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	600000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1500000	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLossCurrent	64420000	usd
CY2023Q2	hlg	Debt Securities Available For Sale Accumulated Gross Unrealized Loss Before Tax Current DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent	111000	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	64309000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLossCurrent	97813000	usd
CY2022Q4	hlg	Debt Securities Available For Sale Accumulated Gross Unrealized Loss Before Tax Current DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent	309000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	97504000	usd
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-200000	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	65800000	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	0	usd
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	0	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	0	usd
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	0	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	0	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	0	usd
CY2023Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2928000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2442000	usd
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	974000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	0	usd
CY2023Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	402000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	0	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	4304000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2442000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10151000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9648000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3725000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2577000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6426000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7071000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	600000	usd
CY2022Q2	us-gaap	Depreciation Depreciation	400000	usd
	us-gaap	Depreciation Depreciation	1200000	usd
	us-gaap	Depreciation Depreciation	700000	usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1000000.0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1004000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-4000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1008000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	0	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	259000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	146000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	113000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4058000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3902000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	156000	usd
CY2022	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	400000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	43000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	400000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1813000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	811000	usd
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2461000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	729000	usd
CY2023Q2	hlg	Accrued Research And Development Costs Current AccruedResearchAndDevelopmentCostsCurrent	2389000	usd
CY2022Q4	hlg	Accrued Research And Development Costs Current AccruedResearchAndDevelopmentCostsCurrent	1313000	usd
CY2023Q2	hlg	Inventory In Transit InventoryInTransit	449000	usd
CY2022Q4	hlg	Inventory In Transit InventoryInTransit	654000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1717000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1570000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	955000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	525000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9784000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5602000	usd
CY2023Q2	hlg	Share Purchase Right Plan Number Of Declared Dividend In Shares SharePurchaseRightPlanNumberOfDeclaredDividendInShares	1	shares
CY2023Q2	hlg	Share Purchase Right Plan Beneficial Ownership Acquired Percentage SharePurchaseRightPlanBeneficialOwnershipAcquiredPercentage	0.125
CY2023Q2	hlg	Share Purchase Right Plan Investors Beneficial Ownership Acquired Percentage SharePurchaseRightPlanInvestorsBeneficialOwnershipAcquiredPercentage	0.20
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-21683000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-20217000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-32227000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-79185000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	198283663	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	188351584	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	196476901	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	186162907	shares
CY2023Q2	hlg	Weighted Average Number Of Shares Assumed Exercise Of Warrants WeightedAverageNumberOfSharesAssumedExerciseOfWarrants	2333178	shares
CY2022Q2	hlg	Weighted Average Number Of Shares Assumed Exercise Of Warrants WeightedAverageNumberOfSharesAssumedExerciseOfWarrants	1830890	shares
	hlg	Weighted Average Number Of Shares Assumed Exercise Of Warrants WeightedAverageNumberOfSharesAssumedExerciseOfWarrants	2291434	shares
	hlg	Weighted Average Number Of Shares Assumed Exercise Of Warrants WeightedAverageNumberOfSharesAssumedExerciseOfWarrants	960830	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	200616841	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	190182474	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	198768335	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	187123737	shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	200616841	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	187123737	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2816000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11578000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-6383000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24560000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2816000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11578000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-6383000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24560000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	usd

Files In Submission

Name	View Source	Status
0001840292-23-000032-index-headers.html	Edgar Link	pending
0001840292-23-000032-index.html	Edgar Link	pending
0001840292-23-000032.txt	Edgar Link	pending
0001840292-23-000032-xbrl.zip	Edgar Link	pending
ex311-2023q210xq.htm	Edgar Link	pending
ex312-2023q210xq.htm	Edgar Link	pending
ex321-2023q210xq.htm	Edgar Link	pending
ex322-2023q210xq.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hlg-20230630.htm	Edgar Link	pending
hlg-20230630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
hlg-20230630_cal.xml	Edgar Link	unprocessable
hlg-20230630_def.xml	Edgar Link	unprocessable
hlg-20230630_lab.xml	Edgar Link	unprocessable
hlg-20230630_pre.xml	Edgar Link	unprocessable
hlg-20230630_htm.xml	Edgar Link	completed
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HLGN
Heliogen, Inc. Stock $hlgn

2023 Q3 Form 10-Q Financial Statement

#000184029223000032 Filed on August 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HLGN Heliogen, Inc. Stock $hlgn

2023 Q3 Form 10-Q Financial Statement

#000184029223000032 Filed on August 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HLGN
Heliogen, Inc. Stock $hlgn